Patient info Open main menu

Sofosbuvir/velpatasvir/voxilaprevir Gilead 200 mg/50 mg/50 mg film-coated tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine strength:
200 mg/50 mg/50 mg
Contains active substance:

Patient leaflet - Sofosbuvir/velpatasvir/voxilaprevir Gilead 200 mg/50 mg/50 mg film-coated tablets

1. What Sofosbuvir/Velpatasvir/ Voxilaprevir Gilead is and what it is used for

Sofosbuvir/Velpatasvir/Voxilaprevir Gilead is a medicine that contains the active substances sofosbuvir, velpatasvir and voxilaprevir in a single tablet. It is given to treat a chronic (long-term) viral infection of the liver called hepatitis C in patients aged 12 years and older and weighing at least 30 kg.

The active substances in this medicine work together by blocking three different proteins that the hepatitis C virus needs to grow and reproduce itself, causing the infection to be eliminated from the body.

2. What you need to know before you take Sofosbuvir/ Velpatasvir/Voxilaprevir Gilead

Do not take Sofosbuvir/Velpatasvir/ Voxilaprevir Gilead

If you are allergic to sofosbuvir, velpatasvir, voxilaprevir or any of the other ingredients of this medicine (listed in section 6 of this leaflet).

➥ If this applies to you, do not take Sofosbuvir/

Velpatasvir/Voxilaprevir Gilead and tell your doctor immediately.

  • If you are currently taking any of the following medicines:

    • rifampicin and rifabutin (antibiotics used to treat infections, including tuberculosis);
    • St. John’s wort (a herbal medicine used to treat depression);
    • carbamazepine, phenobarbital and phenytoin (medicines used to treat epilepsy and prevent seizures); ■ rosuvastatin (a medicine used to treat high blood cholesterol or decrease the risk of certain cardiovascular events);
    • dabigatran (a medicine used to prevent blood clots); ■ ethinylestradiol containing medicines, including many contraceptives.

Warnings and precautions

Talk to your doctor if you:

  • have liver problems other than from hepatitis C, for instance

    • if you have a current or previous infection with the hepatitis B virus, since your doctor may want to monitor you more closely;
    • if you have had a liver transplant.
  • are taking treatment for human immunodeficiency virus (HIV) infection, since your doctor may want to monitor you more closely.

Talk to your doctor or pharmacist before taking Sofosbuvir/Velpatasvir/Voxilaprevir Gilead if:

  • you currently take, or have taken in the last few months, the medicine amiodarone to treat irregular heartbeats, as it may result in a life-threatening slowing of your heart beat. Your doctor may consider alternative treatments if you have taken this medicine. If treatment with Sofosbuvir/Velpatasvir/Voxilaprevir Gilead is needed, you may required additional heart monitoring.
  • you have diabetes. You may need closer monitoring of your blood glucose levels and/or adjustment of your diabetes medication after starting Sofosbuvir/ Velpatasvir/Voxilaprevir Gilead. Some diabetic patients have experienced low sugar levels in the blood (hypoglycaemia) after starting treatment with medicines like Sofosbuvir/Velpatasvir/Voxilaprevir Gilead.

    Tell your doctor immediately if you currently take, or have taken in the last months, any medicines for heart problems and during treatment you experience:

    • slow or irregular heartbeat, or heart rhythm problems;
    • shortness of breath or worsening of existing shortness of breath;
    • chest pain;
    • light-headedness;
    • palpitations;
    • near fainting or fainting.

Blood tests

Your doctor will test your blood before, during and after your treatment with Sofosbuvir/Velpatasvir/Voxilaprevir Gilead. This is so that:

  • Your doctor can decide if you should take Sofosbuvir/ Velpatasvir/Voxilaprevir Gilead and for how long;
  • Your doctor can confirm that your treatment has worked and you are free of the hepatitis C virus.

Children and adolescents

Do not give this medicine to children under 12 years of age and weighing less than 30 kg. The use of Sofosbuvir/ Velpatasvir/Voxilaprevir Gilead in these patients has not yet been studied.

Other medicines and Sofosbuvir/ Velpatasvir/Voxilaprevir Gilead Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

If you are not sure talk to your doctor or pharmacist.

Some medicines must not be taken with Sofosbuvir/ Velpatasvir/Voxilaprevir Gilead. Taking Sofosbuvir/ Velpatasvir/Voxilaprevir Gilead with any of these may stop your medicines from working properly, or make any side effects worse:

  • rifampicin and rifabutin (antibiotics used to treat infections, including tuberculosis);
  • St. John’s wort (a herbal medicine used to treat depression);
  • carbamazepine, phenobarbital and phenytoin (medicines used to treat epilepsy and prevent seizures);
  • rosuvastatin (a medicine used to treat high blood cholesterol or decrease the risk of certain cardiovascular events);
  • dabigatran (a medicine used to prevent blood clots);
  • ethinylestradiol containing medicines, including many contraceptives.

Tell your doctor or pharmacist if you are taking any of the medicines below:

  • amiodarone, used to treat irregular heartbeats;
  • rifapentine (an antibiotic used to treat infections, including tuberculosis);
  • oxcarbazepine (medicine used to treat epilepsy and prevent seizures);
  • tenofovir disoproxil fumarate, or any medicine containing tenofovir disoproxil fumarate, used to treat HIV infection;
  • atazanavir, efavirenz or lopinavir, used to treat HIV infection;
  • digoxin, used to treat heart conditions;
  • modafinil, used to treat sleep disorders;
  • atorvastatin, pravastatin, or other statins, used to treat high cholesterol;
  • ciclosporin, used to suppress the immune system.

    Taking Sofosbuvir/Velpatasvir/Voxilaprevir Gilead with any of these may stop your medicines from working properly, or make any side effects worse. Your doctor may need to give you a different medicine or adjust the dose of medicine you are taking.

    • Get advice from a doctor or pharmacist if you take medicines used to treat stomach ulcers, heartburn or acid reflux as they can decrease the amount of velpatasvir in your blood. These medicines include: ■ antacids (such as aluminium/magnesium hydroxide or calcium carbonate). These should be taken at least 4 hours before or 4 hours after Sofosbuvir/Velpatasvir/ Voxilaprevir Gilead;

      • proton pump inhibitors (such as omeprazole, lansoprazole, rabeprazole, pantoprazole and esomeprazole). If you need high doses of these medicines your doctor may give you a different medicine instead or adjust the dose of the medicine you are taking;
      • H2-receptor antagonists (such as famotidine, cimetidine, nizatidine or ranitidine). If you need high doses of these medicines your doctor may give you a different medicine instead or adjust the dose of the medicine you are taking.

These medicines can decrease the amount of Sofosbuvir/ Velpatasvir/Voxilaprevir Gilead in your blood. If you are taking one of these medicines your doctor will either give you a different medicine for stomach ulcers, heartburn or acid reflux, or recommend how and when you take that medicine.

  • Get advice from a doctor or pharmacist if you take warfarin or other similar medicines called vitamin K antagonists used to thin the blood. Your doctor may need to increase the frequency of your blood tests to check how well your blood can clot.
  • Your liver function may change with treatment of hepatitis C and therefore may affect other medications (e.g. medicines used to suppress your immune system, etc.). Your doctor may need to closely monitor these other medicines you are taking and make adjustments after starting Sofosbuvir/Velpatasvir/Voxilaprevir Gilead.

Pregnancy, breast-feeding and fertility

If you are pregnant, think you may be pregnant, are breast-feeding your baby, or are planning to have a baby ask your doctor for advice before taking this medicine.

Pregnancy

Sofosbuvir/Velpatasvir/Voxilaprevir Gilead is not recommended during pregnancy. The effects of Sofosbuvir/Velpatasvir/Voxilaprevir Gilead during pregnancy are not known.

Breast-feeding

Do not breast-feed during treatment with Sofosbuvir/ Velpatasvir/Voxilaprevir Gilead. Some of the active substances of Sofosbuvir/Velpatasvir/Voxilaprevir Gilead may pass into human breast milk.

Driving and using machines

Sofosbuvir/Velpatasvir/Voxilaprevir Gilead should not affect your ability to drive or use any tools or machinery.

Sofosbuvir/Velpatasvir/Voxilaprevir Gilead contains lactose

  • Tell your doctor if you are lactose intolerant or intolerant to other sugars. Sofosbuvir/Velpatasvir/ Voxilaprevir Gilead contains lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars contact your doctor before taking this medicinal product.

3. How to take Sofosbuvir/ Velpatasvir/Voxilaprevir Gilead

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose of Sofosbuvir/Velpatasvir/ Voxilaprevir Gilead is one 400 mg/100 mg/100 mg tablet or two 200 mg/50 mg/50 mg tablets, taken once a day for 8 or 12 weeks.

Take Sofosbuvir/Velpatasvir/Voxilaprevir Gilead as advised by your doctor.

Swallow the tablet(s) whole with food. Do not chew, crush or split the tablet as it has a very bitter taste.

Kidney problems

Tell your doctor if you have kidney problems or if you are on kidney dialysis, since Sofosbuvir/Velpatasvir/ Voxilaprevir Gilead has not been fully tested in patients with severe kidney problems.

Liver problems

Sofosbuvir/Velpatasvir/Voxilaprevir Gilead should not be used if you have moderate or severe liver problems.

If you are taking an antacid, take it at least 4 hours before or at least 4 hours after Sofosbuvir/Velpatasvir/ Voxilaprevir Gilead.

If you are sick (vomit) after taking Sofosbuvir/ Velpatasvir/Voxilaprevir Gilead it may affect the amount of Sofosbuvir/Velpatasvir/Voxilaprevir Gilead in your blood. This may make Sofosbuvir/Velpatasvir/ Voxilaprevir Gilead work less well.

  • If you are sick (vomit) less than 4 hours after taking Sofosbuvir/Velpatasvir/Voxilaprevir Gilead, take another dose.
  • If you are sick (vomit) more than 4 hours after taking Sofosbuvir/Velpatasvir/Voxilaprevir Gilead, you do not need to take another dose until your next scheduled dose.

If you take more Sofosbuvir/Velpatasvir/ Voxilaprevir Gilead than you should

If you accidentally take more than the recommended dose of Sofosbuvir/Velpatasvir/Voxilaprevir Gilead you may be at increased risk of side effects with this medicine (see section 4 Possible side effects).

Contact your doctor or nearest emergency department immediately for advice. Keep the tablet bottle with you so that you can easily describe what you have taken.

If you forget to take Sofosbuvir/ Velpatasvir/Voxilaprevir Gilead

It is important not to miss a dose of this medicine.

If you do miss a dose, work out how long it is since you last took your Sofosbuvir/Velpatasvir/Voxilaprevir Gilead:

  • If you notice within 18 hours of the time you usually take Sofosbuvir/Velpatasvir/Voxilaprevir Gilead, you must take the missed dose as soon as possible. Then take the next dose at your usual time.
  • If it is 18 hours or more after the time you usually take Sofosbuvir/Velpatasvir/Voxilaprevir Gilead, wait and take the next dose at your usual time. Do not take a double dose (two doses close together).

Do not stop taking Sofosbuvir/ Velpatasvir/Voxilaprevir Gilead

Do not stop taking this medicine unless your doctor tells you to. It is very important that you complete the full course of treatment to give the medicine the best chance to treat your hepatitis C virus infection.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Sofosbuvir/Velpatasvir/ Voxilaprevir Gilead®

200 mg/50 mg/50 mg film-coated tablets

Sofosbuvir/Velpatasvir/

Voxilaprevir Gilead®

200 mg/50 mg/50 mg

film-coated tablets

4. Possible side effects

Like all medicines, this medicine may cause side effects, although not everybody gets them.

Some side effects could be serious.

Stop taking Sofosbuvir/Velpatasvir/Voxilaprevir Gilead and seek medical help immediately if you experience any of the following symptoms:

  • swelling of the face, lips, tongue or throat (angioedema) (an uncommon side effect - may affect up to 1 in 100 people)
  • a wide-spread severe rash with peeling skin which may be accompanied by fever, flu like symptoms, blisters in the mouth, eyes, and/or genitals (Stevens Johnson syndrome) (the frequency of the side effect is not known)

Other side effects that may occur

Very common side effects

(may affect more than 1 in 10 people)

  • headache
  • diarrhoea
  • feeling sick (nausea)

Common side effects

(may affect up to 1 in 10 people)

  • stomach pain
  • decreased appetite
  • being sick (vomiting)
  • muscle pain (myalgia)
  • abnormality in a laboratory test of liver function (total bilirubin)
  • rash

Uncommon side effects

(may affect up to 1 in 100 people)

  • muscle spasms

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the

Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Sofosbuvir/ Velpatasvir/Voxilaprevir Gilead

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the bottle and carton after “EXP”. The expiry date refers to the last day of that month.

This medicine does not require any special temperature storage conditions. Store in the original package in order to protect from moisture. Keep the bottle tightly closed.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Sofosbuvir/Velpatasvir/Voxilaprevir Gilead contains

  • The active substances are sofosbuvir, velpatasvir and voxilaprevir. Each film-coated tablet contains 200 mg sofosbuvir, 50 mg velpatasvir, and 50 mg voxilaprevir.
  • The other ingredients are

    Tablet core:

    Colloidal anhydrous silica, copovidone, croscarmellose sodium (E468), lactose monohydrate, magnesium stearate, microcrystalline cellulose (E460)

    Film-coating:

    Iron oxide black (E172), iron oxide red (E172), iron oxide yellow (E172), macrogol (E1521), polyvinyl alcohol (E1203), talc (E553b), titanium dioxide (E171)

What Sofosbuvir/Velpatasvir/Voxilaprevir Gilead looks like and contents of the pack

Sofosbuvir/Velpatasvir/Voxilaprevir Gilead

200 mg/50 mg/50 mg film-coated tablets are beige, oval-shaped tablets debossed with “GSI” on one side and “SVV” on the other side. The tablet is 15 mm long and 8 mm wide.

The tablets are packed in plastic bottles with child resistant caps. Each bottle contains a silica gel desiccant (drying agent) that must be kept in the bottle to help protect your tablets. The silica gel desiccant is contained in a separate sachet or canister and should not be swallowed.

The following pack size is available:

  • outer cartons containing 1 bottle of 28 film-coated tablets

Marketing Authorisation Holder

Gilead Sciences Ltd

280 High Holborn

London

WC1V 7EE

United Kingdom

Manufacturer

Gilead Sciences Ireland UC

IDA Business & Technology Park

Carrigtohill

County Cork

Ireland

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

Gilead Sciences Ltd

Tel: + (0) 8000 113 700

This leaflet was last revised in 04/2025

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLGB 11972/0054

Last revision stated in the text: April 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Sofosbuvir/velpatasvir/voxilaprevir Gilead 200 mg/50 mg/50 mg film-coated tablets

Active substance Sofosbuvir
Strength 200 mg/50 mg/50 mg
Marketing authorisation PLGB 11972/0054

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.